Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

piedmont

Outpatient Imaging Affiliates inks 2 new hospital joint ventures

The private equity-backed, Tennessee-based imaging group is expanding in Georgia and Missouri through partnerships with Piedmont and BJC HealthCare, respectively. 

Early TAVR for asymptomatic severe AS cuts costs, improves outcomes

The study found lifetime per-patient savings from early TAVR ranged from about $2,334 in the U.K. to $19,607 in Switzerland.

money maze payment reimbursement

Radiology societies join initiative to fight payer restrictions around key interventional service

ACR, SIR and others altogether representing over 100,000 physicians recently wrote to 5 of the 7 Medicare Administrative Contractors to voice their concerns. 

Anthem Elebance blue cross blue shield bcbs

ACR blasts ‘deeply flawed’ Anthem policy targeting out-of-network radiologists

Last month, the insurance giant announced it will begin charging hospitals a 10% administrative penalty for claims that involve docs outside of its networks. 

nasdaq stock market trading wall street

Radiology provider Lumexa Imaging seeks to raise $200M through IPO

If the effort succeeds, the Raleigh, North Carolina-based imaging group would soon begin trading on the Nasdaq under the ticker symbol LMRI. 

Thumbnail

Colorado law barring medical debt from credit reports faces federal challenge from trade lobby

While the law sunsets in 2028, ACA International and the debt collector Creditors Bureau USA are not waiting. They filed a lawsuit in federal court arguing that Colorado is illegally restricting free speech, in violation of the First Amendment. 

Illustration showing how procizumab captures circulating dipeptidyl peptidase 3 (cDPP3) to block this key molecular driver of shock. Illustrations courtesy of 4TEEN4

$64M raised for new cardiogenic shock drug—research already underway

Procizumab was developed to change the trajectory of shock by addressing an underlying molecular driver rather than just managing symptoms.

interventional radiology philips

Interventional radiologists who neglect E&M visits risk losing more lucrative procedures

“This study affirms that when interventional radiologists are afforded the time to evaluate and follow their patients, the complexity and value of the care they provide increases," one expert notes.